ロート製薬の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2024年3月
|
270,840
|
40,048
|
42,434
|
31,394
|
113,554
|
157,286
|
247,036
|
99,139
|
346,175
|
89,210
|
|
214,759
|
87,087
|
209,399
|
14.79%
|
15.67%
|
11.59%
|
71.36%
|
34,245
|
-16,317
|
-13,784
|
12.64%
|
17,928
|
13.59%
|
9.57%
|
0.00013561
|
0.00013521
|
7259人
|
2023年3月
|
238,664
|
33,959
|
35,568
|
26,429
|
101,243
|
137,421
|
215,078
|
94,599
|
309,677
|
79,951
|
|
190,246
|
80,162
|
184,005
|
14.23%
|
14.9%
|
11.07%
|
69.45%
|
30,924
|
-13,176
|
-16,199
|
12.96%
|
17,748
|
13.25%
|
9.04%
|
0.00011562
|
0.00011529
|
7176人
|
2022年3月
|
199,646
|
29,015
|
28,750
|
21,188
|
83,476
|
116,170
|
183,994
|
90,882
|
274,876
|
72,791
|
|
164,306
|
71,488
|
162,304
|
14.53%
|
14.4%
|
10.61%
|
66.94%
|
27,250
|
-16,406
|
3,470
|
13.65%
|
10,844
|
12.44%
|
8.46%
|
0.00009261
|
0.00009234
|
6866人
|
2021年3月
|
181,287
|
22,990
|
23,910
|
16,770
|
74,326
|
106,961
|
156,612
|
69,537
|
226,149
|
52,964
|
|
133,071
|
56,471
|
145,511
|
12.68%
|
13.19%
|
9.25%
|
69.25%
|
20,008
|
-10,237
|
-2,347
|
11.04%
|
9,771
|
11.31%
|
7.59%
|
0.00007339
|
0.00007318
|
6596人
|
2020年3月
|
188,327
|
23,085
|
22,735
|
15,282
|
74,135
|
114,192
|
140,032
|
75,612
|
215,644
|
45,307
|
|
130,706
|
62,117
|
131,985
|
12.26%
|
12.07%
|
8.11%
|
64.94%
|
19,040
|
-9,405
|
-1,603
|
10.11%
|
9,635
|
11.23%
|
7.34%
|
0.00006757
|
0.00006736
|
6619人
|
2019年3月
|
183,582
|
20,812
|
18,970
|
9,818
|
74,048
|
109,534
|
132,189
|
68,764
|
200,953
|
37,856
|
|
116,402
|
60,760
|
119,989
|
11.34%
|
10.33%
|
5.35%
|
65.78%
|
21,745
|
-10,245
|
-3,386
|
11.84%
|
11,500
|
7.53%
|
4.89%
|
0.000043
|
0.00004283
|
6355人
|
2018年3月
|
171,742
|
19,087
|
18,849
|
9,336
|
70,746
|
100,996
|
128,440
|
72,396
|
200,836
|
30,532
|
|
110,050
|
61,332
|
112,696
|
11.11%
|
10.98%
|
5.44%
|
63.95%
|
19,154
|
-11,014
|
-1,823
|
11.15%
|
8,140
|
7.56%
|
4.88%
|
0.00008155
|
0.0000812
|
6448人
|
2017年3月
|
154,599
|
15,451
|
15,964
|
10,013
|
63,254
|
91,345
|
118,436
|
63,107
|
181,543
|
23,924
|
|
100,948
|
53,422
|
106,302
|
9.99%
|
10.33%
|
6.48%
|
65.24%
|
13,428
|
-9,511
|
-2,335
|
8.69%
|
3,917
|
8.72%
|
5.55%
|
0.00008795
|
0.00008757
|
6635人
|
2016年3月
|
167,016
|
15,683
|
15,339
|
9,085
|
67,250
|
99,766
|
111,271
|
68,302
|
179,573
|
23,073
|
|
101,752
|
59,357
|
98,675
|
9.39%
|
9.18%
|
5.44%
|
61.96%
|
11,324
|
-6,066
|
-5,898
|
6.78%
|
5,258
|
8.19%
|
5.09%
|
0.00008004
|
0.0000797
|
6642人
|
2015年3月
|
151,774
|
13,159
|
14,098
|
8,627
|
61,395
|
90,379
|
110,516
|
66,993
|
177,509
|
25,733
|
|
93,692
|
57,607
|
92,315
|
8.67%
|
9.29%
|
5.68%
|
62.26%
|
11,292
|
-9,024
|
-3,375
|
7.44%
|
2,268
|
8.25%
|
5.08%
|
0.00007605
|
0.00007573
|
6426人
|
2014年3月
|
143,822
|
16,821
|
17,100
|
8,947
|
57,924
|
85,898
|
98,627
|
63,622
|
162,249
|
23,028
|
|
82,981
|
56,643
|
86,505
|
11.7%
|
11.89%
|
6.22%
|
60.79%
|
18,661
|
-12,620
|
-5,211
|
12.98%
|
6,041
|
9.3%
|
5.72%
|
0.00007715
|
0.00007682
|
5845人
|
2013年3月
|
129,146
|
14,380
|
14,730
|
8,087
|
52,792
|
76,354
|
93,771
|
56,872
|
150,643
|
19,868
|
|
77,467
|
49,554
|
79,677
|
11.13%
|
11.41%
|
6.26%
|
62.25%
|
16,702
|
-10,595
|
-3,408
|
12.93%
|
6,107
|
9.12%
|
5.64%
|
0.00006878
|
0.00006849
|
5518人
|
2012年3月
|
120,292
|
|
13,684
|
8,184
|
|
|
83,627
|
52,381
|
136,008
|
15,381
|
|
|
|
|
0.0%
|
11.38%
|
6.8%
|
61.49%
|
10,391
|
-9,605
|
800
|
8.64%
|
786
|
|
|
0.0000696
|
0.00006931
|
5347人
|
2011年3月
|
115,472
|
|
13,293
|
7,966
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
11.51%
|
6.9%
|
|
|
|
|
|
|
|
|
0.00006775
|
0.00006746
|
5201人
|
2010年3月
|
113,429
|
|
12,770
|
7,768
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
11.26%
|
6.85%
|
|
|
|
|
|
|
|
|
0.00006606
|
0.00006577
|
4878人
|